Sanofi, Massachusetts General Hospital, Sign Trans Med Agreement
October 9, 2012 | Sanofi has announced a two-year agreement with Massachusetts General Hospital (MGH) aimed at furthering translational medicine research to develop new treatments for various types of hematological malignancies and solid tumors. The project-based collaboration unites scientists from MGH and Sanofi, with the goal of maximizing the strengths of both academic and industry cross-organizational expertise, and will include both pre-clinical and clinical translational research to elucidate questions from proof-of-concept to tolerability, efficacy and effectiveness. Press Release
Click here to log in.
Text Only 2000 character limit
Page 1 of 1